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Abstract
The high fat content in Western diets probably affects placental function during pregnancy with potential consequences for the offspring in the short and
long term. The aim of the present study was to compare genome-wide placental gene expression between rat dams fed a high-fat diet (HFD) and those fed
a control diet for 3 weeks before conception and during gestation. Gene expression was measured by microarray and pathway analysis was performed.
Gene expression differences were replicated by real-time PCR and protein expression was assessed by Western blot analysis. Placental and fetal weights
at E17.25 were not altered by exposure to the maternal HFD. Gene pathways targeting placental growth, blood supply and chemokine signalling were up-
regulated in the placentae of dams fed the HFD. The up-regulation in messenger RNA expression for ﬁve genes Ptgs2 (fatty acid cyclo-oxidase 2; COX2),
Limk1 (LIM domain kinase 1), Pla2g2a (phospholipase A2), Itga1 (integrin α-1) and Serpine1 was conﬁrmed by real-time PCR. Placental protein expression
for COX2 and LIMK was also increased in HFD-fed dams. In conclusion, maternal HFD feeding alters placental gene expression patterns of placental
growth and blood supply and speciﬁcally increases the expression of genes involved in arachidonic acid and PG metabolism. These changes indicate a
placental response to the altered maternal metabolic environment.
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The highly vascularised placenta supplies nutrients to the devel-
oping fetus and epidemiological studies have shown that
impaired fetal growth and the development of adult-onset dis-
ease are strongly associated with compromised placental struc-
ture and function. Converging lines of evidence now suggest
that the placenta plays a signiﬁcant role in intra-uterine program-
ming by conveying critical growth-regulating signals between
mother and fetus. Maternal overnutrition, which is increasingly
common in the developed world, has been reported to alter pla-
cental function and structure and thereby the fetal growth trajec-
tory(1). In C57BL/6 mice, a high-fat diet (HFD) has been found
to induce placental oxidative stress, causing vascular dysfunction
and thereby disrupted nutrient transport(1,2). Similar ﬁndings of
altered vascular development have been reported in the placen-
tae of Sprague–Dawley rats fed a HFD(3). In Japanese macaques
maintained on a chronic HFD, placental expression of a range
of cytokines and Toll-like receptor 4 (TLR-4) is increased when
compared with animals maintained on a normal diet(4). Gene
expression of speciﬁc targets in the placenta has been studied
previously. Recently, it was reported that messenger RNA
(mRNA) expression of GLUT1 (Slc2a1) is down-regulated
whereas that of GLUT3 (Slc2a3) is up-regulated in placentae
from HFD-fed rats(5). Similarly, up-regulation of mRNA
expression of the cationic amino acid transporter Slc7a1 and
Abbreviations: COX2, cyclo-oxidase 2; HFD, high-fat diet; LIMK1, LIM domain kinase 1; mRNA, messenger RNA
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down-regulation of the Na-dependent amino acid transporter
Slc38a4 is observed in the placentae from HFD-fed rats(5).
The mechanisms underlying the changes in placental mor-
phology and gene expression are incompletely described. It is
known, however, that HFD feeding increases the expression
of imprinted genes such as the Igf2r gene(6). This indicates
decreased levels of methylation which may be secondary to
the reported decreased expression levels of the DNA methyl-
transferases Dnmt1 and Dnmt3a(5).
In mice, a HFD exerts distinct effects on genome-wide pla-
cental gene expression(6–8). Mao et al. reported that both a
HFD and a low-fat diet have pronounced and speciﬁc effects
on placental gene expression that are different for male and
female fetuses, with larger changes observed in females(7).
Sexual dimorphic patterns were similarly observed in the
expression and DNA methylation levels of imprinted genes in
the placenta of another mouse model on a HFD(6). When
genome-wide gene expression was studied in this last model,
the HFD altered the placental gene expression of both female
and male fetuses but only a fraction of the genes overlapped
between the sexes. While there have been reports on the effects
of HFD feeding on mRNA expression of speciﬁc placental
genes, there are no studies on the effects of maternal HFD feed-
ing on global placental gene expression in the rat. The aim of the
present study, therefore, was to characterise genome-wide pla-
cental gene expression to identify genes and pathways commonly
affected by HFD feeding in male and female rat fetuses.
Materials and methods
Animals
Female Sprague–Dawley rats, aged 8–9 weeks, were obtained
and allowed to acclimatise for 1 week before diet onset. The ani-
mals were maintained in a light-controlled environment (12 h
light–12 h dark cycle; 24°C) throughout the study. After 1
week, female rats were randomly allocated to a hyperenergetic
HFD (SF08-023; Specialty Feeds) or a control diet
(SF09-091) (Table 1). The fat component of the HFD consisted
of pork lard and rapeseed oil; in the control diet the fat com-
ponent was rapeseed oil only. Both diets contained sucrose,
wheat starch and dextrinised starch as sources of carbohydrates,
although to different extents. The diets had similar contents of
vitamins and minerals. After 3 weeks, the female rats were time-
mated for 3 h with male Sprague–Dawley rats fed a control diet.
This day was designated as embryonic day zero (E0). After mat-
ing, the dams were individually housed and maintained on their
respective diets, having food and water ad libitum until killing at
E17.25, a stage in pregnancy in which there is rapid fetal
growth. Placentae were obtained and weighed, snap-frozen in
liquid N2 and stored at –80°C. Approval was obtained from
the School of Biomedical Sciences Animal Ethics Committee
at Monash University (SOBSA/2008/39).
Gene expression microarray
A quantity of 30 mg placental tissue (wet weight) from one
placenta per dam on the HFD (n 4) or the control diet (n 6)
was homogenised with a mortar and pestle in liquid N2.
RNA was isolated with the AllPrep DNA/RNA mini kit
(Qiagen) according to the manufacturer’s speciﬁcations.
Total RNA was quantiﬁed and its quality assessed on a
Bioanalyser (Agilent 2100). RNA samples with RNA integrity
number >7, 260:280 ratio >2 and 260:230 ratio >1 were
selected for microarray analysis.
Total RNA (500 ng) was converted and biotinylated with
the Illumina TotalPrep RNA ampliﬁcation kit (Illumina).
Biotinylated samples were hybridised to the RatRef-12
Expression BeadChip (Illumina), incorporating twelve samples
per chip. The chip was scanned on a BeadStation 500 System
using Beadscan software v3.5.31. Gene expression data were
normalised by probe-intensity transformation and normalisa-
tion (Lumi package for the analysis of Illumina microarray
data in the bioconductor software suite(9)). Differences in
expression between the HFD and control diets were calculated
with the unpaired Student’s t test, with P < 0·05 considered to
be statistically signiﬁcant. Pathway analysis on up- or down-
regulated genes with a P < 0·05 was based on GO/KEGG
by the Web-based Gene Set Analysis Toolkit (Webgestalt;
http://bioinfo.vanderbilt.edu/webgestalt). A further pathway
analysis was undertaken on a list of genes with a fold-change
of 1·4 for up-regulated genes. Both pathway analyses were
repeated with the DAVID algorithm (http://david.abcc.
ncifcrf.gov) to ensure the validity of the pathway analyses.
Quantitative real-time PCR
Validation of the microarray results for six genes with high
fold-changes was performed by real-time PCR. RNA isolated
from ten individual HFD placentae and ten individual control
placentae (one placenta per dam) that included all the samples
analysed by microarray was reverse transcribed into comp-
lementary DNA (QuantiTect cDNA synthesis kit; Qiagen).
A total of six genes were selected for validation: ﬁve genes
that were up-regulated (Ptgs2, Pla2g2a, Serpine1, Itga1 and
Limk1; encoding for cyclo-oxidase 2, phospholipase A2,
Table 1. Diet composition
Control diet High-fat diet
Protein (%) 19·4 23·3
Total fat (%) 7·0 23·5
Carbohydrates (%) 73·6 53·2
Digestible energy (MJ/kg) 16·1 19·1
Energy from protein (%) 21·0 21·0
Energy from lipids (%) 16·0 42·2
Energy from carbohydrates (%) 63·0 36·8
Fatty acid composition
16 : 0 (%) 0·40 5·60
18 : 0 (%) 0·10 0·10
18 : 1 (%) 4·20 8·60
18 : 2 (%) 1·30 3·60
18 : 3 (%) 0·98 0·50
Total n-3 (%) 0·98 0·73
Total n-6 (%) 1·51 3·63
Total MUFA (%) 3·98 9·22
Total PUFA (%) 2·50 4·47
Total SFA (%) 0·50 9·83
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Serpin1, integrin α-1 and LIM domain kinase 1, respectively)
and one gene that was down-regulated (Umps; encoding for
UMP synthetase). The up-regulated genes had a fold-change
of >1·4 and P < 0·05. The down-regulated gene had a fold-
change of <0·71 and P< 0·05. SYBR green assays were
designed on the National Center for Biotechnology
Information (NCBI) primer design tool. All assays spanned
exon–exon junctions and primer speciﬁcity was veriﬁed by
PrimerBlast (NCBI). Primer sequences can be found in
Supplementary Table 1. Primer efﬁciency was established
and dissociation curve analysis conﬁrmed the presence of
one PCR product at the expected melting temperature. Gene
expression for β-actin (Actb) was used as the endogenous
control. Real-time PCR was performed in a 20 µl volume
with 10 µl SYBR green PCR master mix (Life Technologies),
20 ng complementary DNA and 300 nM forward and reverse
primers, respectively in the StepOnePlus real-time PCR system
(Life Technologies). Gene expression was compared with the
comparative cycle threshold (CT) method (2
−ΔΔC
T ).
Western blot
Placental tissue (50 mg) was homogenised with a mortar and
pestle, and lysed in ProteoJET Mammalian Cell Lysis
Reagent with protease inhibitors (PhosSTOP Phosphatase
Inhibitor Cocktail; Roche Applied Science). Protein concen-
tration was determined by the bicinchoninic acid method
with bovine serum albumin as the protein standard (Pierce,
ThermoFisher Scientiﬁc). A quantity of 30 µg of total protein
was loaded onto NuPAGE Bis-Tris Gel (4–12 or 12 %) (Life
Technologies). Proteins were transferred onto PVDF (polyvi-
nylidene ﬂuoride) membranes (Millipore). The membrane was
blocked in 5 % skimmed milk in PBS–Tween for 1 h at room
temperature before overnight incubation with primary anti-
body for fatty acid cyclo-oxidase 2 (COX2) (sc-7951; Santa
Cruz) and β-actin (A5316, SigmaAldrich) at 4°C. Secondary
horseradish peroxidase (HRP)-conjugated antibodies (donkey
anti rabbit HRP, Sigma 90545 and donkey anti mouse HRP,
Santa Cruz Biotechnology 2314) were incubated for 1 h at
room temperature in a Super Signal West Dura, extended dur-
ation (Pierce 34075) and the blots were developed for 5 min
before scanning on the GS0800 imaging system (BioRad).
For LIMK1, rabbit primary antibody (ab81046; Abcam)
Secondary LI-COR® antibody (goat anti-rabbit 800CW
LI-COR® 926-32211 and donkey anti-mouse 680LT
LI-COR® 926-68022) was incubated for 1 h at room tempera-
ture and protein was detected by the Odyssey Infrared
Imaging System (LI-COR Biosciences). Protein expression
was analysed by densitometry, with β-actin used to normalise
for differences in protein loading.
Statistical analysis
Individual placentae were investigated for all experiments, and
each placenta was obtained from an independent litter. For all
analyses, between-group comparisons of the means were made
with unpaired Student’s t test after conﬁrming that the data
were normally distributed. The microarray analyses were
performed on six placentae from dams on the control diet
and four placentae from dams on the HFD. The quantitative
PCR replication experiments were carried out on RNA iso-
lated from ten placentae per group. The Western blot analyses
were performed on protein from ten placentae each for
COX2, and on protein from nine placentae from the control
diet group and six HFD placentae for LIMK1. Data were pre-
sented as mean values with their standard errors; P < 0·05 was
considered to be statistically signiﬁcant.
Results
Fetal and placental weights
Fetal and placental weights were similar in the control and
HFD groups at E17.25.
Fetal weights were similar in rats on the control diet (0·69
(SEM 0·02) g) and the HFD (0·68 (SEM 0·03) g; P = 0·87) as
were placental weights (control diet 0·36 (SEM 0·02) v. HFD
0·35 (SEM 0·02) g; P = 0·91). Maternal weights were not differ-
ent at E17.25 between the diet groups (control diet 328·5
(SEM 33·4) v. HFD 347·5 (SEM 33·3) g; P = 0·69).
Genome-wide gene expression
Microarray analysis of placental RNA from six dams on the
control diet and four dams on the HFD yielded 825 differen-
tially expressed genes with a cut-off of P < 0·05; none of the
genes were differentially expressed after correction for multiple
testing. Of the 825 genes, there were 457 annotated genes with
327 up-regulated and 130 down-regulated genes in the placen-
tae of dams on the HFD (Supplementary Table 2). Pathway
analyses were performed separately for up-regulated and
down-regulated genes on the basis of the KEGG/GO data-
base with two different algorithms, with the top ten pathways
for each presented in Table 2.
Pathway analysis was also performed on nineteen
up-regulated genes with a fold-change larger than 1·4 in
HFD-fed dams (Supplementary Table 3). The pathway analy-
sis was based on the gene ontology database and seven path-
ways were found with the Webgestalt tool (Table 3); all of
these were repeated with the DAVID pathway analysis tool.
The main pathways included regulation of apoptosis, growth
regulation, circulation and chemotaxis.
The microarray results were conﬁrmed by real-time PCR for
ﬁve up-regulated genes and one down-regulated gene with high
fold-changes: Limk1, Itga1, Pla2g2a, Ptgs2, Serpine1 and Umps.
These genes were selected based on their known functions
and their prominence in the pathway analyses. Differential
expression was observed for the genes that were up-regulated
in placentae from HFD-fed dams, for example, Limk1 (fold-
change 4·1), Itga1 (fold-change 1·8), Pla2g2a (fold-change 1·9),
Ptgs2 (fold-change 1·9), Serpine1 (fold-change 2·0) but not for
the down-regulated gene Umps (fold-change 1·7) (Fig. 1). We
investigated if the change in mRNA expression translated to a
change in protein expression for fatty acid COX2 (EC
1·44·99·1), which is encoded by Ptgs2, and the serine/threonine
kinase LIMK1, which is encoded by Limk1.
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Protein expression
Compared with controls, placentae from dams fed the HFD
showed a 1·3-fold increase in protein expression of COX2
(control diet 0·64 (SEM 0·050) v. HFD 0·81 (SEM 0·051);
P < 0·05) in line with the increased mRNA expression
(Fig. 2(a)). Similarly, LIMK1 was found to have increased
protein expression by 1·4-fold in placentae from HFD-fed
dams (control diet 0·16 (SEM 0·017) v. HFD 0·22 (SEM
0·009); P < 0·05) (Fig. 2(b)).
Discussion
The aim of the present study was to establish the effects of a
maternal HFD on rat placental gene expression using a
genome-wide approach. The HFD was associated with the
differential expression of more than 800 placental probes, cor-
responding to 457 known genes. Many of the up-regulated
genes in the HFD group were associated with signal transduc-
tion pathways, including those involving phospholipid-derived
mediators, cytokines and chemokines. This is not unexpected
given the known associations of HFD feeding with low-grade
inﬂammation(10,11). Metabolic pathways in the placenta were
also signiﬁcantly affected by the HFD. Regulation of metabolic
pathways in the placenta by overnutrition and undernutrition
has been reported previously in mouse models(7,12), speciﬁ-
cally, placental expression differences between male and
female offspring of dams on a control diet for amino acid
and carbohydrate metabolism pathways and for lipid metab-
olism in HFD-fed dams but not in metabolism pathways
Table 3. Pathway analysis based on gene ontology in the Webgestalt pathway analysis tool with eighteen up-regulated genes with a fold-change >1·4 or
down-regulated with a fold-change <0·7
Pathway (total number of genes in pathway) O E R P Adjusted P
Regulation of apoptosis (729) 5 0·97 5·15 0·0021 0·044
Includes Ptgs2 and Itga1
Regulation of angiogenesis (59) 2 0·08 25·47 0·0027 0·044
Includes Serpine1
Cell chemotaxis (47) 2 0·06 31·97 0·0017 0·044
Includes Itga1
Regulation of anatomical structure size (347) 4 0·46 8·66 0·001 0·044
Includes Ptgs2, Limk1 and Itga1
Developmental growth (173) 3 0·23 13·03 0·0015 0·044
Includes Ptgs2, Limk1 and Serpine2
Blood circulation (204) 3 0·27 5·09 0·0023 0·044
Includes Ptgs2 and Itga1
Oxidoreductase activity, acting on single donors with
incorporation of molecular oxygen (38)
2 0·04 47·65 0·0008 0·034
Includes Ptgs2
O, Observed number of genes; E, expected number of genes; R, O:E ratio.
Table 2. Pathway analysis of all up-regulated and down-regulated genes with P < 0·05 with the Webgestalt pathway analysis tool
Pathway (total number of genes in pathway) O E R P Adjusted P
Up-regulated genes
Metabolic pathways (1169)* 28 8·09 3·46 1·6 × 10−8 1·34 × 10−6
MAPK signalling (269)* 10 1·76 5·37 2·07 × 10−5 0·0009
1C pool by folate (18)* 3 0·12 24·10 0·0002 0·0028
Lysosome (124)* 6 0·86 7·00 0·0002 0·0028
Antigen processing and presentation (91)* 5 0·63 7·94 0·0004 0·0048
Alzheimer’s disease (212) 8 1·47 5·46 0·0001 0·0021
Apoptosis (93)* 4 0·64 6·22 0·0040 0·026
Glycosphingolipid biosynthesis – ganglio series (15)* 2 0·10 19·28 0·0047 0·026
Chemokine signalling (178) 5 1·23 4·06 0·0082 0·035
Arachidonic acid metabolism (74) 3 0·51 5·86 0·0148 0·042
Down-regulated genes
Alzheimer’s disease (212)* 5 0·56 8·99 0·0003 0·0075
RNA degradation (77)* 3 0·20 14·85 0·0011 0·0081
Peroxisome (80)* 3 0·21 14·29 0·0012 0·0081
Proximal tubule bicarbonate reclamation (20) 2 0·05 38·11 0·0013 0·0081
Metabolic pathways (1169)* 9 3·07 2·93 0·0038 0·016
Leucocyte transendothelial migration (114) 3 0·30 10·03 0·0034 0·016
Tight junction (131)* 3 0·34 8·73 0·0061 0·018
Notch signalling (50) 2 0·13 15·24 0·0077 0·024
Basal cell carcinoma (53) 2 0·14 14·38 0·0086 0·024
Pathways in cancer (319) 4 0·84 4·78 0·0101 0·025
O, Observed number of genes; E, expected number of genes; R, O:E ratio; MAPK, mitogen-activated protein kinase.
* Pathways also found with the DAVID pathway analysis algorithm.
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between the diets(8). In addition, pathway analyses indicated
that methylation may be altered by HFD feeding since
mRNA expression of genes in the 1C pool by folate pathway
was signiﬁcantly altered. This is in accordance with the results
obtained by Lin et al.(5) who reported that expression levels of
the DNA methyltransferases Dnmt1 and Dnmt3a were
decreased in the placenta of rats fed a HFD. In female off-
spring of mouse dams fed a HFD, decreased expression of
Dnmt3l has been reported(8). Decreased levels of methylation
could result in increased levels of gene expression. In the pre-
sent study, the HFD resulted in increased gene expression of
more genes than the number of genes with decreased levels of
gene expression.
The pathway analysis conducted including only the nineteen
up-regulated genes with a fold-change of >1·4 indicated altera-
tions in pathways that modulate angiogenesis and circulating
blood as well as growth and development. Heightened
expression of genes in these pathways could lead to increased
growth of the placenta and thereby the fetus. HFD feeding in
mice has been reported to increase offspring neonatal fat
mass(13). At E17.25 there were no differences in either placen-
tal or fetal weight, and although fetal weight increased by
approximately 2·3 g between E17.25 and birth there were no
effects on fetal weight caused by the maternal HFD (data
not shown).
The pathway analysis of down-regulated genes yielded three
pathways common to both pathway analyses: Alzheimer’s dis-
ease, RNA metabolism and cell adhesion. The Alzheimer’s
disease pathway encompasses many cellular processes includ-
ing receptor signalling, oxidative phosphorylation and Ca sig-
nalling, which all lead to apoptosis. Alzheimer’s disease has
been associated with the metabolic syndrome in humans(14)
Fig. 1. Replication of microarray results with real-time PCR for Pla2g2a, encoding for phospholipase A2 (a), Ptgs2, encoding for cyclo-oxidase 2 (b), Limk1, encoding
for LIM domain kinase 1 (c), Itga1, encoding for integrin α-1 (d), Serpine1, encoding for Serpin1 (e) and Umps, encoding for UMP synthetase (f). mRNA, messenger
RNA; AU, arbitrary units; HFD, high-fat diet. Values are means (n 10 placentae (one placenta per dam) in each group), with standard errors represented by vertical
bars. Mean value was significantly different from that of the control group: *P < 0·05, **P < 0·01, ***P < 0·001.
Fig. 2. Placental protein expression of cyclo-oxidase 2 (COX2) (a) and LIM
domain kinase 1 (LIMK1) (b). AU, arbitrary units; HFD, high-fat diet. Values
are means (n 10 placentae (one placenta per dam) in each group for COX2;
n 9 in control group and n 6 in HFD group for LIMK1), with standard errors rep-
resented by vertical bars. *Mean value was significantly different from that of
the control group (P < 0·05).
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and Wistar Kyoto rats fed a HFD show increases in the levels
of biomarkers for Alzheimer’s disease(15). Apoptosis was one
of the main pathways that we reported for the analysis with all
genes that were differentially expressed in the placentae of
dams on the HFD or the control diet. Decreases in this path-
way could result in reduced levels of apoptosis and could
thereby also lead to increased placental and fetal size.
Indeed, increased levels of placental apoptosis have previously
been correlated to reduced placental size in primate and rodent
models of maternal undernutrition(12,16,17).
The arachidonic acid metabolism pathway was also signiﬁ-
cantly altered in the placentae of rats fed the HFD. COX2
belongs to this pathway and its mRNA and protein expression
was increased in placentae from HFD-fed rat dams. mRNA
for Ptgs2, Ptgs1 and the PG-metabolising enzyme Hpgd was
increased in the placentae of female but not male offspring
of HFD-fed mouse dams at E12.5(7). In humans, increased
placental mRNA expression of PTGS2 has been reported in
pregnancies complicated with pre-eclampsia in some(18,19)
but not all studies(20,21). This increase in expression was loca-
lised to the syncytiotrophoblast cells(18). In pre-eclampsia, the
vascularisation of the placenta is dysregulated(22,23). Fetal poly-
morphisms in PTGS2 have been shown to cause placental
malperfusion in 132 twin pregnancies(24), again indicating a
role for COX2 in placental blood ﬂow. The mRNA expression
of Pla2g2a, which encodes for phospholipase A2, the enzyme
catalysing the reaction from phosphatidylcholine to arachido-
nic acid and lysophosphatidylcholine, was also increased,
providing substrate for COX2. A high gene expression of
phospholipase A2 was also reported in placentae from obese
neonates and was correlated to accumulation of n-3 fatty
acids(25). In the present study, neonatal circulating n-3 fatty
acids and neonatal body composition were not measured.
Expression for LIMK1 showed the largest difference in
expression between the control diet and the HFD. LIMK1
encodes a serine/threonine protein kinase which contains
two LIM domains. It is a modulator of actin and microtubule
dynamics(26) and has been implicated in the mitotic process(27).
In the mouse, LIMK1 has been shown to be expressed early in
the embryo as well as in trophoblast giant cells(28).
A limitation of the present study is the relatively small
sample size. This precluded an analysis of the effects of sex
in the response to HFD feeding. In mice, genome-wide pla-
cental gene expression has been carried out and analysis has
shown that HFD feeding resulted in differential gene
expression of many genes in a sexually dimorphic pattern,
with females showing larger changes than males(6–8). In
these studies, a slightly larger number of placentae or pools
of placentae were studied for each condition and results
were not corrected for multiple testing either. However, the
present study found changes in similar genes(7) and similar
pathways(8) to the studies in mice, indicating common effects
of a HFD on placental gene expression.
Conclusion
Maternal HFD feeding alters placental gene expression at
E17.25, with pathways promoting inﬂammation and growth
being over-represented among up-regulated genes and those
affecting apoptosis among down-regulated genes. COX2,
phospholipase A2 and LIMK1 mRNA and protein expression
were up-regulated after maternal HFD feeding, implicating
arachidonic acid and PG metabolism as targets of maternal
diet effects.
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